BioCentury
ARTICLE | Company News

GlaxoSmithKline endocrine news

January 24, 2011 8:00 AM UTC

GlaxoSmithKline expects to record a legal charge of £2.2 billion ($3.5 billion) in 4Q10 related to additional provisioning for the investigation by the U.S. Attorney's Office for the District of Color...